Vascular endothelial growth factor in patients with high-altitude pulmonary edema

J Appl Physiol (1985). 2003 May;94(5):1836-40. doi: 10.1152/japplphysiol.00575.2002. Epub 2003 Jan 10.

Abstract

To examine the role of VEGF in the pathogenesis of high-altitude pulmonary edema (HAPE), we measured the concentrations of VEGF in venous serum and bronchoalveolar lavage fluid in patients with HAPE and in healthy volunteers. The VEGF in venous serum of the patients was normal at admission and significantly increased at recovery. Similarly, the VEGF in bronchoalveolar lavage fluid of the patients was increased at recovery compared with admission, but values at both admission and recovery were significantly lower than those of the controls. The present finding suggests that VEGF probably is destroyed in the lung of HAPE, and it appears less likely to have a critical part in the pathogenesis of HAPE but has rather an important role in the repair process for the impaired cell layer.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Altitude Sickness / metabolism*
  • Altitude Sickness / physiopathology
  • Bronchoalveolar Lavage Fluid / chemistry
  • C-Reactive Protein / metabolism
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Leukocyte Count
  • Male
  • Pulmonary Edema / metabolism*
  • Pulmonary Edema / physiopathology
  • Vascular Endothelial Growth Factor A / blood
  • Vascular Endothelial Growth Factor A / metabolism*

Substances

  • Vascular Endothelial Growth Factor A
  • C-Reactive Protein